Skip to main content
PGNY
NASDAQ Industrial Applications And Services

Progyny Director/Officer Anevski Notices Sale of 314,738 Shares (~$9.5M)

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Health Tech Stocks · Healthcare
Sentiment info
Negative
Importance info
7
Price
$34.37
Mkt Cap
$2.637B
52W Low
$16.1
52W High
$35.5
52W Position info
113% above low
Off High info
3.2% below high
Rel. Volume info
2.5× avg
Market data snapshot near publication time

PGNY has more than doubled off its 52-week low of $16.1 on elevated volume (2.5× avg).

Summary

Progyny director/officer Peter Anevski filed to sell 314,738 shares worth roughly $9.47M from option exercises under a 10b5-1 plan—a much larger sale than recent insider filings and timed just after a Q3 beat.


Key Events · Ownership and Investor Activity · PGNY

  • Large Insider Sale Noticed

    Director/officer Peter Anevski filed a Form 144 to sell 314,738 shares worth approximately $9,473,614, acquired via option exercise.

  • Pre-Planned 10b5-1 Sale

    The sale is under a 10b5-1 plan adopted 07/02/2026, so it is scheduled rather than a discretionary open-market decision.

  • Far Larger Than Recent Sales

    Recent insider Form 144s covered 11,500, 3,903 and 1,879 shares; this notice is roughly 27x the largest of those.

  • Timed After Q3 Beat

    The notice follows the 2026-11-04 Q3 report showing revenue of $341.3M (+8.9%) and EPS of $0.32, with the stock near its 52-week high.


Analysis · PGNY · Industrial Applications And Services

A director and officer has filed intent to sell 314,738 shares worth about $9.47M, acquired through option exercise under a 10b5-1 plan adopted 07/02/2026. That is far larger than the recent insider sales of 11,500, 3,903 and 1,879 shares, and it lands the day after a strong Q3 beat and guidance raise, with the stock near its 52-week high. Because the sale is a pre-planned liquidity event rather than an open-market conviction signal, the size alone makes it the most notable insider distribution in the recent pattern.

How filings like this one have moved

In the 30 days to Nov 17, 2026, 38% of the 3791 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, PGNY was trading at $34.37 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $2.6B. The 52-week trading range was $16.10 to $35.50. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

PGNY - Latest Insights

PGNY
Nov 05, 2026, 8:56 AM EST
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $30.60
Real-time Price: $35.44 info
Change: +$4.84 (+16%) info
Market Cap: $2.611B info
PGNY
Nov 04, 2026, 4:12 PM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $30.10
Real-time Price: $35.44 info
Change: +$5.34 (+18%) info
Market Cap: $2.611B info
PGNY
Nov 04, 2026, 4:01 PM EST
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $30.04
Real-time Price: $35.44 info
Change: +$5.40 (+18%) info
Market Cap: $2.611B info
PGNY
Aug 07, 2026, 9:00 AM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $26.24
Real-time Price: $35.44 info
Change: +$9.20 (+35%) info
Market Cap: $2.611B info
PGNY
Aug 06, 2026, 4:10 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $26.83
Real-time Price: $35.44 info
Change: +$8.61 (+32%) info
Market Cap: $2.611B info